Evidence check: Skincare DNA in the context of Blutzucker

Evidence for DNA-based skincare advice linked to blood sugar (Blutzucker) is weak and largely marketing-driven. While plausible mechanisms exist (e.g., glycation from high glucose damages collagen), there are no robust clinical trials showing that specific genetic variants (e.g., in AGE receptor or collagen genes) justify personalized skincare based on blood sugar. Most consumer tests rely on small-effect GWAS associations. Blood sugar itself is far more reliably assessed via fasting glucose, HbA1c, or continuous glucose monitoring. A DNA test may offer marginal insight but should not replace medical evaluation. Caution: supplement recommendations from such tests (e.g., high-dose vitamin C or collagen) lack RCT support and may be risky in certain conditions. Evidence: marketing/mixed. Sources: none directly in provided context.